Leishmaniasis, Cutaneous: Clinical Trials

1 trial for Leishmaniasis, Cutaneous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Leishmaniasis, Cutaneous: new trials by email Literature Review of Leishmaniasis, Cutaneous trials Research Report on Leishmaniasis, Cutaneous

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
Liposomal meglumine antimoniate (Glucantime), Liposomal meglumine antimoniate, Liposomal Paromomycin - Cutaneous Leishmaniasis
Early Phase 1CompletedTehran University of Medical Sciences302011-03-012012-06-20

Broader conditions

Euglenozoa Infections (1)  ·  Infections (1)  ·  Leishmaniasis (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Skin Diseases, Parasitic (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vector Borne Diseases (1)

Interventions

Meglumine Antimoniate (1)

Sponsors

Tehran University of Medical Sciences (1)

Countries

Iran (1)

Top investigators

Ali Khamesipour, MPH, PhD (1)  ·  Mahmoud Reza Jaafari, Parm D, PhD (1)  ·  Masud Maleki, MD (1)